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As fibrosis and melanosis are often seen in malignant melanoma, the presence of dermoscopic signs of regression may represent
a clue for the diagnosis of malignancy. Our aim was to assess the frequency and extent of 11 dermoscopic features of regression
evaluating dermoscopic images of 111 melanomas in situ (MIS). Regression structures (grey-blue areas, white areas, peppering,
and/or blue-whitish veil) were present in 80.1% of the lesions. Approximately 80% of the lesions showed regression of dermoscopic
structures and light brown areas. Most lesions showed the presence of grey-blue areas (74.7%), whereas peppering was observable
in 30.6% of MIS. Areas of fibrosis were mainly observable as structureless areas with a pinkish hue (50.4%). Based on our data, the
reticular pattern of blue regression and light brown areas can be considered a significant discriminator and a reliable predictor of
MIS.
1. Introduction
Regression structures are employed for detection of malig-
nant melanoma (MM) by dermoscopy and are defined by
the presence of white and grey-blue areas in the dermoscopic
lesion image [1–3]. White areas have been described as
areas whiter than the surrounding skin (white scar-like
areas), whereas grey-blue areas appear as homogeneous
or nonhomogeneous areas (blue pepper-like granules or
globules) with a bluish color [3–5]. White and blue colours
in a melanocytic lesion may be simultaneously or sepa-
rately present, suggesting a different therapeutic approach;
moreover, their distribution and their location in the centre
or at the periphery of the lesion may represent an aid
to distinguish between different subtypes of melanocytic
lesions [3]. Histopathologically, blue regression may corre-
spond to an abundance of melanin pigment, within either
melanophages or pigmented melanocytes in the dermis
[6], whereas in the presence of the classic blue-whitish
veil, histopathology shows an acanthotic epidermis with
compact orthokeratosis and focal hypergranulosis above
sheets of heavily pigmented melanocytes or melanophages
in the dermis [6–8]. Lesions with regression often carry
great histopathological controversy. However, the presence
of dermoscopic signs of regression may represent a clue for
the diagnosis of malignant lesions. In our previous paper,
comparing the regression features observed in 85 MIS, 85
invasive MMs, and 85 nevi with equivocal dermoscopic
aspects, the presence of a blue-whitish veil was more
frequently seen in invasive MMs, while grey-blue areas with
a reticular pattern represented a significant descriptor for
MIS [9]. The aim of the present study is to expand the
study population with respect to our previous publication,
evaluating the dermoscopic features of 111 lesions for the
presence of 11 parameters of regression.
2. Material and Methods
The study population included 111 consecutive lesions,
excised at the Department of Dermatology of the University
of Modena in the years 2003–2009, where we assessed the
presence or absence of 11 parameters of regression (Table 1).
The dermoscopic images were evaluated by 3 experienced
dermatologists. Final judgment on each descriptor derived
from a consensus of at least 2 of 3 observers.
Dermoscopic descriptors. Regression was considered
present when grey-blue areas, peppering, blue-whitish veil,
and/or white areas were present. Grey-blue areas were
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Figure 1: Reticular grey-grey-blue areas. (a) In situ melanoma with reticular grey-blue pigmentation in the centre of the lesion (30-fold
magnification). (b) Detail of a 50-fold magnified in situ melanoma, where reticular grey-grey-blue areas are well detectable.
Table 1: Eleven variables of regression and their definitions.
Parameter Definition
(1) Regression
Presence of grey-blue areas and/or
peppering and/or blue-whitish veil
and/or white areas
(2) Grey-blue areas
Bluish and/or larger areas of grey-blue
pigmentation
(a) Structureless Grey-blue homogeneous pigmentation
(b) Reticular
Coarse blue-grey net, with thick
grey-blue lines and large holes
(c) Globular Aggregated grey-blue globules
(3) Peppering Blue, fine pepper-like structures
(4) White areas White scar-like areas
(5) Blue-whitish veil
Compact, structureless, irregular, and
confluent blue-whitish pigmentation.
Similar to a superficial veil, palpable over
the lesion
(6) Pink areas
Areas of the lesion lighter than the
surrounding skin with a pinkish shade
(7) Light brown areas Light brown structureless irregular areas
(8) Regression of
dermoscopic structures
Fading of net, globules, or pigmentation
giving rise to light brown areas or small
structureless areas within a structured
area
further described as being globular, reticular, or structureless
(Figure 1). “Globular grey-grey-blue areas” were represented
by aggregated grey-blue globules, whereas the term “reticular
grey-grey-blue areas” defined a coarse blue-grey net, with
thick grey-blue lines and large holes, corresponding to white
or pink regression areas (Figure 2). Although often present
in lesions with a network, reticular grey-blue pigmentation
does not correspond to the pigment network, which has
smaller meshes and thinner lines. Pink lesion areas, as areas
of the lesion lighter than the surrounding skin with a pinkish
shade, were also observed. For blue and white areas, both
their presence and their extent were assessed. Unlike in our
Table 2: Frequency (%) of regression descriptors in melanoma in
situ (MIS).
MIS (111 = 100%)
Regression present 80.1
Regression of dermoscopic structures 81.9
Light brown areas 81.0
Grey-blue areas 74.7
Pink areas 50.4
Peppering 30.6
White areas 10.8
Blue-whitish veil 1.8
previous paper, the presence of the blue-whitish veil was
only considered when the lesion was clinically palpable.
Moreover, we also considered the presence of regression of
dermoscopic structures and light brown areas defined as light
brown structureless irregular areas especially located at the
periphery of the lesions [10] “Regression of dermoscopic
structures” was visible when, within a structured area, there
was a fading of net, globules, or pigmentation giving rise to
light brown structureless areas.
3. Statistics
Absolute and relative frequencies of the observations were
obtained for each regression parameter. Absolute and relative
frequencies of lesions showing only one or a combination of
the evaluated dermoscopic features were calculated on the
number of lesions presenting regression.
4. Results
The study included a total of 111 melanocytic lesions diag-
nosed as MIS according to conventional histopathological
criteria. These were located on the trunk and limbs of 110
patients (50 female and 60 male, mean ± SD age 56.4 ± 15.7
years).
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Figure 2: Association of different dermoscopic aspects of regression. (a) In situ melanoma showing white and pink areas as well as blue
structureless areas (original magnification ×20). (b) Dermoscopic image of an in situ melanoma showing blue structureless and globular
areas associated with peppering (original magnification ×20).
Table 3: Frequency (%) of pattern and extent of grey-blue areas in
MIS.
Grey-blue areas MIS showing grey-blue areas (83 = 100%)
Structureless 59.0
Reticular 66.2
Globular 21.6
<10% 19.2
10–50% 54.2
>50% 26.5
Table 2 shows the results of the assessment of regression
parameters in 111 MIS. Regression structures (i.e., grey-
blue areas, white areas, peppering, and/or blue-whitish veil)
were present in 80.1% of the lesions. Approximately 80%
of the lesions showed regression of dermoscopic structures
and light brown areas. Most MIS showed the presence of
grey-blue areas (74.7%), whereas peppering was observable
in 30.6% of MIS. Areas of fibrosis seldom appeared as white
areas (10.8%) but were rather observable as structureless
areas with a pinkish hue (50.4%). In our series of MIS,
the blue-whitish veil was noticed in only 1.8% of the cases
(Figures 1 and 2).
Table 3 shows data regarding pattern and extent of grey-
grey-blue areas. The reticular pattern was themost frequently
observed along with the structureless pattern. Grey-grey-
blue areas involved 10–50% of the lesion area in more than
half of the cases.
Table 4 shows the number of regression parameters in the
study population. One regression parameter was present in
64% of MIS. The presence of two regression descriptors was
found in 25.8% of MIS, whereas 3 regression parameters or
more were observed in 10.1% of cases in our population.
When subdividing our cases according to the diameter
of the lesion, we observed a higher percentage of lesions
showing regression, in particular grey-grey-blue areas and
Table 4: Number of regression parameters in lesions with regres-
sion (%).
Number of regression
parameters
MIS with regression (89 = 100%)
1 64
2 25.8
≥3 10.1
white/pink structures, in MIS with a diameter >1 cm
(Table 5).
5. Discussion
Blue-white structures, corresponding to histological regres-
sion phenomena, are one of the most interesting dermo-
scopic features commonly seen in melanomas and represent
a clue for the diagnosis [3, 11–16]. Blue-white structures
in dermoscopy include white areas, scar-like or associated
with a reddish shade, grey-grey-blue areas, or a combination
of both. Histologically, white areas correspond to fibrosis,
whereas grey-grey-blue areas correspond to melanophages in
the dermis [17, 18]. Dermoscopically, grey-blue areas and the
blue-whitish veil are difficult to distinguish, and this causes a
low reproducibility in the identification of these features [12–
16, 19–23]. Therefore, they are generally considered together
and described by the unifying definition of blue structures
[24].
In our previously published paper, comparing the der-
moscopic features of regression in equivocal lesions, MIS,
and invasive MMs, we found that regression is not only more
frequent and extensive in invasiveMMswith respect to in situ
lesions, but it also has a different morphological expression
[9].
In the present study, features of regression were re-
evaluated on 111 lesions histologically diagnosed as MIS,
assessing the extent, the morphology, and the correlation
of regression features, also according to the diameter of
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Table 5: Frequency (%) of patterns of regression features according
to lesion diameter.
Lesion diameter
≤1 cm (68 = 100%) >1 cm (43 = 100%)
Regression features 75 88.3
Grey-blue areas
(number of lesions
≤1 cm and >1 cm)
70.5 81.3
White/pink areas 36.7 72
the lesion. The results substantially confirm the data we
obtained in the previous study: regression structures were
present in 80% of cases and were mainly represented by grey-
blue areas with a reticular pattern and structureless light
brown pigmentation. Grey-blue areas can represent the only
expression of regression features, or, less frequently, they can
be associated to peppering. Unlike in our previous study, the
presence of the blue-whitish veil was only considered when
the lesion was clinically palpable; therefore, only few lesions
with this feature were identified by our evaluation.
We also observed that regression features, as expressed by
the presence of grey-blue areas and white/pink structures are
more frequently observable in large lesions indicating that
the regression process evolves with the radial growth of the
MM.
In MIS, grey-grey-blue areas are presumably due to a
deep melanophagic infiltration. Light brown areas may rep-
resent the start of the regression phenomenon, followed by
a disarrangement later expressed by reticular blue structures.
In lesion zones of MIS corresponding to light brown areas,
the disappearance of the rete ridges and the scarcity of
intraepidermal melanin may explain the lack of an evident
pigment network and the light brown diffuse pigmentation
[10].
In conclusion, our study provides data about frequency,
morphology, extent, and distribution of regression in a large
population of MIS of different size. Confirming the findings
of our previous paper, we can state that the identification
of the reticular pattern of blue regression is a significant
discriminator and a reliable predictor of MIS, extremely
useful for the diagnosis of early melanoma.
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